Sangeun Lee

Prof. Dr. Sangeun Lee

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
SLSangeun Lee
Sangeun Lee
SNSarah Nasr
Sarah Nasr
SRSari Rasheed
Sari Rasheed
YLYun Liu
Yun Liu
OHOlga Hartwig
Olga Hartwig
CLClaus-Michael Lehr
Claus-Michael Lehr

24 May 2024 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Open access
MKMohamed A.M. Kamal
Mohamed A.M. Kamal
JBJustine Bassil
Justine Bassil
BLBrigitta Loretz
Brigitta Loretz
AHAnna K.H. Hirsch
Anna K.H. Hirsch
SLSangeun Lee
Sangeun Lee
CLClaus-Michael Lehr
Claus-Michael Lehr
Antimicrobial resistance is becoming more prominent day after day due to a number of mechanisms by microbes, especially the sophisticated biological barriers of bacteria, especially in Gram-negatives. There, the lipopolysaccharides (LPS) layer is a unique component of the outer leaflet of the outer membrane which is highly impermeable and prevents antibiotics from passing passively into the intracellular compartments. Biodynamers, a novel class of dynamically bio-responsive polymers, may open new perspectives to overcome this particular barrier by accommodating various secondary structures and form supramolecular structures in such bacterial microenvironments. Generally, bio-responsive polymers are not only candidates as bio-active molecules against bacteria but also carriers via their interactions with the cargo. Singh et al. (2019) [1] Based on their dynamicity, design flexibility, biodegradability, biocompatibility, and pH-responsiveness, we investigated the potential of two peptide-based biodynamers for improving antimicrobial drug delivery. By a range of experimental methods, we discovered a greater affinity of Arg-biodynamers for bacterial membranes than for mammalian membranes as well as an enhanced LPS targeting on the bacterial membrane, opening perspectives for enhancing the delivery of antimicrobials across the Gram-negative bacterial cell envelope. This could be explained by the change of the secondary structure of Arg-biodynamers into a predominant β-sheet character in the LPS microenvironment, by contrast to the α-helical structure typically observed for most lipid membrane-permeabilizing peptides. In comparison to poly-L-arginine, the intrinsic antibacterial activity of Arg-biodynamers was nearly unchanged, but its toxicity against mammalian cells was >128-fold reduced. When used in bacterio as an antibiotic potentiator, however, Arg-biodynamers improved the minimum inhibitory concentration (MIC) against Escherichia coli by 32 times compared to colistin alone. Similar effect has also been observed in two stains of Pseudomonas aeruginosa. Arg-biodynamers may therefore represent an interesting option as an adjuvant for antibiotics against Gram-negative bacteria and to overcome antimicrobial resistance.

27 December 2019 in Materials Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
SLSangeun Lee
Sangeun Lee
CKCansu Kaya
Cansu Kaya
HJHongje Jang
Hongje Jang
MKMarcus Koch
Marcus Koch
BLBrigitta Loretz
Brigitta Loretz
AHAnna Hirsch
Anna Hirsch
The spherical micelles of the carbazole monomer transformed into nanorods in the course of the polymerization. The polymeric nanorods show pH-dependent changes in fluorescence emission and size.

31 July 2023 in Biomacromolecules
Verified
Journal Article
Closed access
YLYun Liu
Yun Liu
SASalma Ashmawy
Salma Ashmawy
LLLorenz Latta
Lorenz Latta
AWAgnes-Valencia Weiss
Agnes-Valencia Weiss
AKAlexander F. Kiefer
Alexander F. Kiefer
CLClaus-Michael Lehr
Claus-Michael Lehr

18 July 2025 in Biomacromolecules
Verified
Journal Article
Open access
RBRudrarup Bose
Rudrarup Bose
DRDaniele Rossetto
Daniele Rossetto
ATAnju Tomar
Anju Tomar
SLSangeun Lee
Sangeun Lee
SMSheref S. Mansy
Sheref S. Mansy
TTT.-Y. Dora Tang
T.-Y. Dora Tang
Macromolecular assembly between biomolecules dictates the material state of chemically complex aqueous dispersions such as the cytoplasm. The formation of protein precipitates, fibers, or liquid droplets have been associated with metabolic regulation and disease. However, the effect of metabolic flux on the material properties of aqueous dispersions remains underexplored. Here, we use the protometabolic reduction of NAD+ to NADH by pyruvate to study the effect of NADH production on the phase separation properties of polyarginine. We show that reduction of NAD+ in the presence of polyarginine can tune the material properties of the dispersion between precipitates, homogeneous solution, and liquid droplets depending on the buffer concentration. In situ droplet formation results in 2-3 times higher reaction rate and NADH yield, compared to homogeneous solution. Our study provides a setting for coupling protometabolism to active protocell environments in the absence of enzymes and sheds light on the self-regulation of metabolic flux on mediating biomolecular phase separation.

29 March 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CPCamilla Passi
Camilla Passi
ANArmin Novak
Armin Novak
Marc SchneiderMarc Schneider
Marc Schneider
SLSangeun Lee
Sangeun Lee
Polymer–drug conjugates (PDCs) represent an advanced drug delivery strategy designed to address critical limitations of conventional therapeutics, including poor water solubility, rapid systemic clearance, and off-target toxicity. By covalently linking therapeutic agents to polymeric carriers through rationally designed linkers, PDCs enable improved pharmacokinetic profiles, enhanced stability, and controlled drug release. This review provides a comprehensive overview of the key design principles governing PDC systems, with a particular focus on the role of biofunctional polymers. Essential parameters for polymer selection, including biocompatibility, biodegradability, molecular weight, and functional group availability, are discussed in relation to their influence on drug loading, release kinetics, and biological performance. In addition, both natural and synthetic polymers are evaluated for their ability to improve solubility, modulate biodistribution, and reduce systemic toxicity. An overview of stimuli-responsive PDCs is provided, including pH-, redox-, and temperature-sensitive systems, which enable site-specific and spatiotemporally controlled drug release in response to pathological microenvironments. We emphasize the special role of bioactive polymers such as poly-lysine, hyaluronic acid, chitosan, and gelatin for their intrinsic biological activity, including receptor-mediated targeting, antimicrobial activity, and synergistic therapeutic effects. These properties support the development of dual-active conjugates with enhanced specificity and efficacy. Overall, this review underscores the transition of polymers from passive carriers to active therapeutic components and outlines current challenges and future perspectives for the clinical translation of next-generation PDCs.